Blank Cover Image

Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant

フォーマット:
論文
責任表示:
Ishiyama, Ken ; Takami, Akiyoshi ; Kanda, Yoshinobu ; Nakao, Shinji ; Hidaka, Michihiro ; Maeda, Tetsuo ; Naoe, Tomoki ; Taniguchi, Shuichi ; Kawa, Keisei ; Nagamura, Tokiko ; Tabuchi, Ken ; Atsuta, Yoshiko ; Sakamaki, Hisashi
言語:
英語
出版情報:
Nature Publishing Group, 2012-03-01
著者名:
Ishiyama, Ken
Takami, Akiyoshi
Kanda, Yoshinobu
Nakao, Shinji
Hidaka, Michihiro
Maeda, Tetsuo
Naoe, Tomoki
Taniguchi, Shuichi
Kawa, Keisei
Nagamura, Tokiko
Tabuchi, Ken
Atsuta, Yoshiko
Sakamaki, Hisashi
続きを見る
掲載情報:
Leukemia
ISSN:
0887-6924  CiNii Research  Webcat Plus  JAIRO
巻:
26
通号:
3
開始ページ:
461
終了ページ:
464
バージョン:
author
概要:
We have recently reported that the outcome of acute myeloid leukemia (AML) patients with t(6;9)(p23;q34) who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) was comparable to that of patients with a normal karyotype . We performed a further analysis regarding the prognostic factors for t(6;9)(p23;q34) AML patients who underwent a HSCT. Seven pediatric patients and 57 adult patients, transplanted between 1996 and 2007, were assessed in this study. The overall survival (OS) of the pediatric patients tended to be better than the OS of the adults, although there were no statistically significant differences. The present study focused on the adult patients revealed that the disease status at HSCT was the sole prognostic factor affecting the OS identified in the univariate analysis. A multivariate analysis showed that the disease status at HSCT and M2 in the FAB classification were extracted as the significant variables affecting the OS. The patients who were not in remission at HSCT and had non-FAB-M2 showed a poorer outcome; 6 deaths in the 9 patients were due to a relapse of the AML. These findings suggest that novel therapeutic approaches might be needed for patients with these poor prognostic factors.<br />発行後6か月より全文公開  続きを見る
URL:
http://hdl.handle.net/2297/30378
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Ishiyama, Ken, Takami, Akiyoshi, Kanda, Yoshinobu, Nakao, Shinji, Hidaka, Michihiro, Maeda, Tetsuo, Naoe, Tomoki, &hellip;

Nature Publishing Group

Nishiyama, Yoshiaki, NiShiyama, Nobuaki

Institute of Science and Engineering, Kanazawa University

Ishiyama, Ken, Yamaguchi, Takuhiro, Eto, Tetsuya, Ohashi, Kazuteru, Uchida, Naoyuki, Kanamori, Heiwa, Fukuda, Takahiro, &hellip;

Elsevier

Ishiyama, Ken, Katagiri, Takamasa, Ohata, K., Hosokawa, Kohei, Kondo, Yukio, Yamazaki, Hirohito, Takami, Akiyoshi, &hellip;

John Wiley and Sons

Hosokawa, Kohei, Yamazaki, Hiroto, Mochizuki, K., Ohata, K., Ishiyama, K., Hayashi, Tomoe, Kondo, Y., Sugimori, Naomi, &hellip;

John Wiley & Sons A/S

石山, 謙, Ishiyama, Ken

日本血液学会 = The Japanese Society of Hematology

Mochizuki, Kanako, Sugimori, Chiharu, Qi, Zhirong, Lu, Xuzhang, Takami, Akiyoshi, Ishiyama, Ken, Kondo, Yukio, Yamazaki, &hellip;

American Society of Hematology

Ishiyama, Ken, Okumura, Hirokazu, Yamazaki, Hirohito, Kondo, Yukio, Waseda, Yuko, Kotani, Takeharu, Takami, Akiyoshi, &hellip;

Nature Publishing Group

Mochizuki, Kanako, Sugimori, Chiharu, Qi, Zhirong, Lu, Xuzhang, Takami, Akiyoshi, Ishiyama, Ken, Kondo, Yukio, Yamazaki, &hellip;

American Society of Hematology

Okumura, Hirokazu, Ohtake, Shigeki, Ontachi, Yasuo, Ozaki, Jun, Shimadoi, Shigeru, Waseda, Yuko, Kondo, Yukio, Yamazaki, &hellip;

日本血液学会

Hosokawa, Kohei, Yamazaki, Hirohito, Nishitsuji, Masaru, Kobayashi, Satoshi, Takami, Akiyoshi, Fujimura, Masaki, Nakao, &hellip;

the Japanese Society of Internal Medicine = 日本内科学会

Espinoza, J. Luis, Takami, Akiyoshi, Trung, Ly Q., Nakao, Shinji

Japanese Cancer Association / Blackwell Publishing Ltd